ScholarIQanswers from OpenAlex & ORCID
Maggie C.U. Cheang
ResearcherPublications, citations & collaboration network
Maggie C.U. Cheang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Maggie C.U. Cheang have?
ScholarIQindexed works
Maggie C.U. Cheang has 456 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Maggie C.U. Cheang have?
ScholarIQcitation count
Maggie C.U. Cheang has 34,366 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Maggie C.U. Cheang?
ScholarIQh-index
Maggie C.U. Cheang has an h-index of 64 in OpenAlex.
What is the i10-index of Maggie C.U. Cheang?
ScholarIQi10-index
Maggie C.U. Cheang has an i10-index of 115 in OpenAlex.
What is the ORCID of Maggie C.U. Cheang?
ScholarIQorcid
The ORCID for Maggie C.U. Cheang is on the source record.
What is the OpenAlex record for Maggie C.U. Cheang?
ScholarIQopenalex
The OpenAlex for Maggie C.U. Cheang is on the source record.
What are the most-cited papers on Maggie C.U. Cheang?
ScholarIQmost cited works
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Lisa A. Carey, Charles M. Perou, Chad Livasy, Lynn G. Dressler, David P. Cowan, Kathleen Conway, Gamze Karaca, Melissa A. Troester, Chiu Kit Tse, Sharon N. Edmiston, Sandra L. Deming, Joseph Geradts, Maggie C.U. Cheang, Torsten O. Nielsen, Patricia G. Moorman, H. Shelton Earp, Robert C. Millikan
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
Torsten O. Nielsen, Forrest D. Hsu, Kristin C. Jensen, Maggie C.U. Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez‐Boussard, Chad Livasy, Dave Cowan, Lynn G. Dressler, Lars A. Akslen, Joseph Ragaz, Allen M. Gown, C. Blake Gilks, Matt van de Rijn, Charles M. Perou
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
Fiona M. Blows, Kristy Driver, Marjanka K. Schmidt, Annegien Broeks, Flora E. van Leeuwen, Jelle Wesseling, Maggie C.U. Cheang, Karen A. Gelmon, Torsten O. Nielsen, Carl Blomqvist, Päivi Heikkilä, Tuomas Heikkinen, Heli Nevanlinna, Lars A. Akslen, Louis R. Bégin, William D. Foulkes, Fergus J. Couch, Xianshu Wang, Vicky Cafourek, Janet E. Olson, Laura Baglietto, Graham G. Giles, Gianluca Severi, Catriona McLean, Melissa C. Southey, Emad A. Rakha, Andrew R. Green, Ian O. Ellis, Mark E. Sherman, Jolanta Lissowska, William F. Anderson, Angela Cox, Simon S. Cross, Malcolm Reed, Elena Provenzano, Sarah‐Jane Dawson, Alison M. Dunning, Manjeet K. Humphreys, Douglas F. Easton, Montserrat García‐Closas, Carlos Caldas, Paul D.P. Pharoah, David G. Huntsman
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac García-Murillas, Gaia Schiavon, Britta Weigelt, Charlotte K.Y. Ng, Sarah Hrebien, Rosalind Cutts, Maggie C.U. Cheang, Peter Osin, Ashutosh Nerurkar, Iwanka Kozarewa, Javier Armisen Garrido, Mitch Dowsett, Jorge S. Reis‐Filho, Ian E. Smith, Nicholas C. Turner
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
Andrew Tutt, Holly Tovey, Maggie C.U. Cheang, Sarah Kernaghan, Lucy Kilburn, Patrycja Gazińska, Julie Owen, Jacinta Abraham, Sophie Barrett, Peter Barrett‐Lee, Robert Brown, Stephen Chan, Mitch Dowsett, James M. Flanagan, Lisa Fox, Anita Grigoriadis, Alexander Gutin, Catherine Harper‐Wynne, M. Hatton, Katherine A. Hoadley, Jyoti Parikh, Peter J. Parker, Charles M. Perou, Rebecca Roylance, Vandna Shah, Adam Shaw, Ian E. Smith, Kirsten M. Timms, Andrew Wardley, G. Wilson, Cheryl Gillett, Jerry S. Lanchbury, Alan Ashworth, Nazneen Rahman, Mark Harries, Paul Ellis, Sarah E. Pinder, Judith M. Bliss